The future of the benzylisoquinolinium relaxants

@article{Savarese1995TheFO,
  title={The future of the benzylisoquinolinium relaxants},
  author={J. Savarese and W. Wastila},
  journal={Acta Anaesthesiologica Scandinavica},
  year={1995},
  volume={39}
}
  • J. Savarese, W. Wastila
  • Published 1995
  • Medicine
  • Acta Anaesthesiologica Scandinavica
  • The benzylisoquinolinium relaxants currently include the intermediate‐acting agent, atracurium, and the short‐acting agent, mivacurium. This class of relaxants has always retained the distinct advantages of rapid degradation, enzymatic metabolism, or both in the plasma, resulting in short half‐lives and fast, complete recovery, unrelated to dose or duration of administration. Any improvements in this class of relaxants must focus on retaining this property at the same time as decreasing or… CONTINUE READING
    15 Citations

    Topics from this paper.

    The continuing search for a succinylcholine replacement.
    • 24
    • PDF
    Local allergic reaction to atracurium besylate: an uncommon and unique reason
    • 1
    • PDF

    References

    SHOWING 1-10 OF 33 REFERENCES
    Clinical pharmacology of atracurium given in high dose.
    • 20